贵州医药
貴州醫藥
귀주의약
GUIZHOU MEDICAL JOURNAL
2015年
5期
385-387
,共3页
李世川%张湘燕%廖强%张程
李世川%張湘燕%廖彊%張程
리세천%장상연%료강%장정
慢性阻塞性肺疾病%支气管扩张试验%临床分析
慢性阻塞性肺疾病%支氣管擴張試驗%臨床分析
만성조새성폐질병%지기관확장시험%림상분석
COPD%Bronchial dilation test%Clinical analysis
目的:对慢性阻塞性肺疾病(COPD)合并支气管舒张试验阳性患者的主要辅助检查进行分析,为该病的诊治提供临床资料。方法2013年4-12月选取60例COPD患者为研究对象,其中支气管舒张试验阳性者30例为研究组,阴性者30例为对照组。分析两组药前及药后1 s用力呼气容积占预计值百分比(FEV 1% pred)、1 s用力呼气容积与用力肺活量的比值(FEV 1/FVC)、二氧化碳分压(PaCO2)、氧分压(PaO2)及血常规等相关结果的差异。结果研究组药前FEV 1% pred、FEV1/FVC%较对照组降低;但药后该指标较对照组升高,差异均有统计学意义(P<0.05);血常规检查示:嗜酸性粒细胞计数较对照组升高,差异亦有统计学意义(P<0.01);而血气分析指标 PaO2、PaCO2以及外周血血红蛋白计数与对照组比较,差异均无统计学意义( P>0.05)。结论嗜酸粒细胞浸润可能是COPD出现气道高反应性的重要原因;该类患者气道阻塞程度在未有效治疗前可能较无气道高反应性的患者更重;但在支气管扩张剂治疗后其阻塞程度明显改善,易于逆转,因此应该进一步加强治疗。
目的:對慢性阻塞性肺疾病(COPD)閤併支氣管舒張試驗暘性患者的主要輔助檢查進行分析,為該病的診治提供臨床資料。方法2013年4-12月選取60例COPD患者為研究對象,其中支氣管舒張試驗暘性者30例為研究組,陰性者30例為對照組。分析兩組藥前及藥後1 s用力呼氣容積佔預計值百分比(FEV 1% pred)、1 s用力呼氣容積與用力肺活量的比值(FEV 1/FVC)、二氧化碳分壓(PaCO2)、氧分壓(PaO2)及血常規等相關結果的差異。結果研究組藥前FEV 1% pred、FEV1/FVC%較對照組降低;但藥後該指標較對照組升高,差異均有統計學意義(P<0.05);血常規檢查示:嗜痠性粒細胞計數較對照組升高,差異亦有統計學意義(P<0.01);而血氣分析指標 PaO2、PaCO2以及外週血血紅蛋白計數與對照組比較,差異均無統計學意義( P>0.05)。結論嗜痠粒細胞浸潤可能是COPD齣現氣道高反應性的重要原因;該類患者氣道阻塞程度在未有效治療前可能較無氣道高反應性的患者更重;但在支氣管擴張劑治療後其阻塞程度明顯改善,易于逆轉,因此應該進一步加彊治療。
목적:대만성조새성폐질병(COPD)합병지기관서장시험양성환자적주요보조검사진행분석,위해병적진치제공림상자료。방법2013년4-12월선취60례COPD환자위연구대상,기중지기관서장시험양성자30례위연구조,음성자30례위대조조。분석량조약전급약후1 s용력호기용적점예계치백분비(FEV 1% pred)、1 s용력호기용적여용력폐활량적비치(FEV 1/FVC)、이양화탄분압(PaCO2)、양분압(PaO2)급혈상규등상관결과적차이。결과연구조약전FEV 1% pred、FEV1/FVC%교대조조강저;단약후해지표교대조조승고,차이균유통계학의의(P<0.05);혈상규검사시:기산성립세포계수교대조조승고,차이역유통계학의의(P<0.01);이혈기분석지표 PaO2、PaCO2이급외주혈혈홍단백계수여대조조비교,차이균무통계학의의( P>0.05)。결론기산립세포침윤가능시COPD출현기도고반응성적중요원인;해류환자기도조새정도재미유효치료전가능교무기도고반응성적환자경중;단재지기관확장제치료후기조새정도명현개선,역우역전,인차응해진일보가강치료。
Objective To analyze the important parameters of clinical assistant examination for patients with COPD and positive bronchial dilation test ,aimed at providing some essential clinical data or information for the re‐lated‐disease diagnosis and treatment .Method 60 stable COPD patients were selected from April 2013 to December 2013 ,among which 30 cases with positive bronchial dilation test were randomly selected as the study group ,while other 30 ones with negative bronchial dilation test as the control group .Some parameters were analyzed such as the forced expiratory volume percent predicted (FEV1% pred) ,partial pressure of carbon dioxide (PaCO2 ) ,partial pressure of oxygen (PaO2 ) ,routine blood test and so on .Result The ratios of FEV1% pred and FEV1/FVC% were lower in study group than in control group before inhalation of bronchodilator ,while they turned higher in study group after inhalation of the drug (all P<0 .05 ) .Eosinophilic cell counts in peripheral blood were higher in study group than the control group ,but no differences found in PaO2 ,PaCO2 and hemoglobin levels between the two groups (all P<0 .05) .Conclusion The infiltration of eosinophils may be involved in airway hyperresponsiveness in COPD cases .Patients with airway hyperresponsiveness may have more severe airway obstruction than those without airway hyperresponsiveness .But after inhalation of bronchodilator ,this kind of obstruction may be improved more in the former than in the latter ,which should be paid more attentions in clinic .